JS207, Junshi Biosciences’ independently developed recombinant humanized anti-PD-1/VEGF bispecific antibody, has demonstrated promising anti-tumor activity and a manageable safety profile in both ...
Based on a proposal prepared by the Board of Directors’ Audit Committee, the Board proposes to the Annual General Meeting ...
To access live webcasts of the presentations, please visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations . Archived versions of the webcasts will be available ...
ATLANTA, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Countdown For A Cure (CFAC) hosted its third annual Evening of Energy gala on February 7th at The St. Regis Atlanta, raising more than $1 million to advance ...
Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and ...
STOCKHOLM, Sweden, February 24, 2026. KDventures AB (Nasdaq Stockholm: KDV) announces that the planned reversed acquisition of the portfolio company SVF Vaccines by Novakand Pharma will not be ...
SAN FRANCISCO and RICHARDSON, Texas, Feb. 24, 2026 (GLOBE NEWSWIRE) -- TextNow, the leading ad-supported U.S. free wireless service, and Mavenir, the disruptive cloud-native telco technology provider, ...
Radiant becomes one of the world’s first infrastructure companies engineered from the ground up to deliver integrated AI compute. Radiant’s access to scaled capital from Brookfield, alongside data ...
Nu-Tek to meet with global biopharma leaders to showcase the strategic importance of 100% animal-free raw materials during DCAT Week 2026 in New York City. MINNETONKA, Minn., Feb. 24, 2026 (GLOBE ...
Alveus Therapeutics Inc. (“Alveus”), a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, today announced the second and final closing of its ...
14:15 London, 16:15 Helsinki, 24 February 2026 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) ...
Valmet has published the Annual Report, the Corporate Governance Statement and the Remuneration Report for 2025 Valmet Oyj's stock exchange release on February 24, 2026 at 13:45 p.m. EET ...